Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEco Animal Regulatory News (EAH)

Share Price Information for Eco Animal (EAH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 112.50
Bid: 110.00
Ask: 115.00
Change: 0.00 (0.00%)
Spread: 5.00 (4.545%)
Open: 112.50
High: 114.00
Low: 112.50
Prev. Close: 112.50
EAH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Regulatory Approval

22 Jan 2018 07:00

ECO Animal Health Group plc

(AIM: EAH)

ECO RECEIVES UKRANIAN MARKETING AUTHORISATIONS FOR AIVLOSIN® FOR PIGS AND POULTRY

ECO Animal Health Group plc is pleased to announce that its subsidiary ECO Animal Health Limited (ECO) has received a number of marketing authorisations for Aivlosin® from the Department for Food Safety and Veterinary from the State Service of Ukraine on Food Safety and Consumer Protection.

Aivlosin ® , ECO’s patented antimicrobial, is used for the treatment of a variety of economically important respiratory and enteric (gut) diseases in pigs and poultry.

These authorisations, which are for the use of Aivlosin® 625 mg/g water soluble granules and Aivlosin® 42.5 mg/g premix for both pigs and poultry, also allow ECO to start selling Aivlosin® in the Ukraine for the medication of drinking water or for mixing into feed, for the treatment of infections caused by Mycoplasma in poultry laying eggs for human consumption, with a zero day drug withdrawal period for eggs.

These new treatments meet all the guidelines for the responsible use of antimicrobials. Importantly, with global concerns about the use of antibiotics in food production animals, these treatments are under the control of veterinarians, available under prescription only and have low, highly effective therapeutic dose rates, a short treatment duration and a zero day or very short drug withholding period.

Peter Lawrence, Chairman of ECO, commented “We are extremely pleased to receive these marketing authorisations for Aivlosin® in the Ukraine, the sixteenth largest egg producing country and one that is ranked just outside the top twenty globally for pork production.”

The information contained within this announcement is deemed by the Group to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 ("MAR"). Upon the publication of this announcement via a Regulatory Information Service ("RIS"), this inside information is now considered to be in the public domain.

Contacts:

ECO Animal Health Group plc

Peter Lawrence   020 8336 6190
Marc Loomes 020 8447 6906
Spiro Financial
Anthony Spiro 020 8336 6196
N+1 Singer (Nominated Adviser) 020 7496 3000
Mark Taylor, Brough Ransom
Peel Hunt LLP (Joint Broker)
James Steel, Dr Christopher Golden 020 7418 8900
 

ECO Animal Health Group plc is a leader in the development, registration and marketing of pharmaceutical products for animals. Our products for these global growth markets promote well-being. Our financial goals are achieved through the careful and responsible application of science to generate value for our shareholders

View source version on businesswire.com: http://www.businesswire.com/news/home/20180121005079/en/

Copyright Business Wire 2018

Date   Source Headline
17th Oct 20129:50 amBUSIssue of Equity
5th Oct 201211:28 amBUSIssue of Equity
27th Sep 20121:08 pmBUSResult of AGM
13th Sep 201210:39 amBUSCirc re.Scrip Dividend Circular
13th Sep 201210:38 amBUSCirc re.Annual Report and Accounts 2012
20th Jul 20124:55 pmBUSFurther re Dividend Record Date
20th Jul 20127:00 amBUSFinal Results
10th Jul 20127:00 amBUSRegulatory Approval
2nd May 20128:00 amBUSHolding(s) in Company
14th Mar 20123:56 pmBUSDirector/PDMR Shareholding
26th Jan 20123:10 pmBUSHolding(s) in Company
18th Jan 201210:14 amBUSHolding(s) in Company
16th Jan 201212:44 pmBUSIssue of Equity
12th Dec 20117:00 amBUSHalf-yearly Report
30th Nov 201112:10 pmBUSHolding(s) in Company
28th Nov 20117:00 amBUSRegulatory Approval
21st Oct 20113:56 pmBUSDirector/PDMR Shareholding
12th Oct 201110:22 amBUSHolding(s) in Company
7th Oct 20113:00 pmBUSDirector/PDMR Shareholding
3rd Oct 201111:48 amBUSHolding(s) in Company
27th Sep 20112:56 pmBUSIssue of Equity
23rd Sep 201111:38 amBUSIssue of Equity
2nd Sep 20111:11 pmBUSResult of AGM
25th Aug 20117:00 amBUSCirc re.Scrip Dividend
29th Jul 201111:35 amBUSIssue of Equity
1st Jul 20117:00 amBUSNotice of Results
29th Mar 20112:16 pmBUSHolding(s) in Company
14th Mar 20111:44 pmBUSFurther re ECOpharma Inc, Japan
15th Dec 20101:04 pmBUSIssue of Equity
8th Dec 20104:05 pmBUSNotice of Results
8th Dec 20107:00 amBUSHalf-yearly Report
28th Sep 201012:27 pmBUSResult of AGM
24th Sep 201011:33 amBUSHolding(s) in Company
24th Sep 201011:17 amBUSHolding(s) in Company
24th Sep 20107:00 amBUSIssue of Equity
17th Sep 20102:08 pmBUSDirector/PDMR Shareholding
26th Aug 20107:00 amBUSPosting of Scrip Dividend Circular
10th Aug 20107:00 amBUSFinal Results
4th Aug 201011:12 amBUSDoc re. Posting of documents to shareholders
26th Jul 20107:00 amBUSRegulatory Approval
30th Jul 20087:00 amRNSPreliminary Results
17th Dec 20077:00 amRNSInterim Results
23rd Jul 20077:00 amRNSFinal Results
23rd Jul 20077:00 amRNSIssue of Equity
27th Nov 200611:56 amRNSResult of EGM
3rd Nov 20067:30 amRNSAcquistion and Placing
13th Oct 200611:30 amRNSStatement re. Disposal
13th Oct 200611:30 amRNSPossible Acquisition
26th Jul 20067:01 amRNSFinal Results
7th Apr 200611:31 amRNSSAR 3 - Lawrence Plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.